Cargando…
Pemafibrate Protects Against Retinal Dysfunction in a Murine Model of Diabetic Retinopathy
Diabetic retinopathy (DR) is one of the leading causes of blindness globally. Retinal neuronal abnormalities occur in the early stage in DR. Therefore, maintaining retinal neuronal activity in DR may prevent vision loss. Previously, pemafibrate, a novel selective peroxisome proliferator-activated re...
Autores principales: | Tomita, Yohei, Lee, Deokho, Miwa, Yukihiro, Jiang, Xiaoyan, Ohta, Masayuki, Tsubota, Kazuo, Kurihara, Toshihide |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7503472/ https://www.ncbi.nlm.nih.gov/pubmed/32872333 http://dx.doi.org/10.3390/ijms21176243 |
Ejemplares similares
-
Pemafibrate Prevents Retinal Pathological Neovascularization by Increasing FGF21 Level in a Murine Oxygen-Induced Retinopathy Model
por: Tomita, Yohei, et al.
Publicado: (2019) -
Pemafibrate Prevents Retinal Dysfunction in a Mouse Model of Unilateral Common Carotid Artery Occlusion
por: Lee, Deokho, et al.
Publicado: (2021) -
Fenofibrate Protects against Retinal Dysfunction in a Murine Model of Common Carotid Artery Occlusion-Induced Ocular Ischemia
por: Lee, Deokho, et al.
Publicado: (2021) -
Pemafibrate prevents choroidal neovascularization in a mouse model of neovascular age-related macular degeneration
por: Lee, Deokho, et al.
Publicado: (2023) -
Pemafibrate, a potent selective peroxisome proliferator-activated receptor α modulator, a promising novel treatment for ischemic retinopathy?
por: Lee, Deokho, et al.
Publicado: (2022)